Literature DB >> 30806817

Intractable Generalized Epilepsy: Therapeutic Approaches.

Sean T Hwang1, Scott J Stevens2, Aradia X Fu2, Simona V Proteasa2.   

Abstract

PURPOSE OF REVIEW: To summarize recent developments in therapeutic options, both medical and surgical, for patients with drug-resistant generalized epilepsy syndromes, which continue to be a multifaceted challenge for patients and physicians. RECENT
FINDINGS: Newer generation pharmaceutical options are now available, such as brivaracetam, rufinamide, lacosamide, perampanel, and cannabidiol. Less restrictive dietary options appear to be nearly as effective as classic ketogenic diet for amelioration of seizures. The latest implantable devices include responsive neurostimulation and deep brain stimulation. Corpus callosotomy is an effective treatment for some seizure types, and newer and less invasive approaches are being explored. Resective surgical options have demonstrated success in carefully selected patients despite generalized electrographic findings on electroencephalogram. The current literature reflects a widening range of clinical experience with newer anticonvulsant medications including cannabinoids, dietary therapies, surgical approaches, and neurostimulation devices for patients with intractable generalized epilepsy.

Entities:  

Keywords:  Drug resistant; Generalized epilepsy; Intractable; Refractory

Mesh:

Substances:

Year:  2019        PMID: 30806817     DOI: 10.1007/s11910-019-0933-z

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  79 in total

1.  Use of Vagus Nerve Stimulator on Children With Primary Generalized Epilepsy.

Authors:  William P Welch; Bilal Sitwat; Yoshimi Sogawa
Journal:  J Child Neurol       Date:  2018-04-13       Impact factor: 1.987

2.  Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.

Authors:  Norman Delanty; John Jones; Françoise Tonner
Journal:  Epilepsia       Date:  2011-11-02       Impact factor: 5.864

Review 3.  Incidence, prevalence and aetiology of seizures and epilepsy in children.

Authors:  Peter Camfield; Carol Camfield
Journal:  Epileptic Disord       Date:  2015-06       Impact factor: 1.819

4.  Validation of corpus callosotomy after laser interstitial thermal therapy: a multimodal approach.

Authors:  Kurt R Lehner; Erin M Yeagle; Miklos Argyelan; Zoltán Klimaj; Victor Du; Pierre Megevand; Sean T Hwang; Ashesh D Mehta
Journal:  J Neurosurg       Date:  2018-11-01       Impact factor: 5.115

Review 5.  Corpus callosotomy outcomes in pediatric patients: A systematic review.

Authors:  David Graham; Martin M Tisdall; Deepak Gill
Journal:  Epilepsia       Date:  2016-05-29       Impact factor: 5.864

6.  Single and staged laser interstitial thermal therapy ablation for cortical tubers causing refractory epilepsy in pediatric patients.

Authors:  Zulma Tovar-Spinoza; Robert Ziechmann; Stephanie Zyck
Journal:  Neurosurg Focus       Date:  2018-09       Impact factor: 4.047

7.  Modified Atkins diet is an effective treatment for children with Doose syndrome.

Authors:  Adelheid Wiemer-Kruel; Edda Haberlandt; Hans Hartmann; Gabriele Wohlrab; Thomas Bast
Journal:  Epilepsia       Date:  2017-02-23       Impact factor: 5.864

Review 8.  Vagus nerve stimulation (VNS) therapy update.

Authors:  James W Wheless; Andrew J Gienapp; Phillippe Ryvlin
Journal:  Epilepsy Behav       Date:  2018-07-13       Impact factor: 2.937

Review 9.  The new definition and classification of seizures and epilepsy.

Authors:  Jessica J Falco-Walter; Ingrid E Scheffer; Robert S Fisher
Journal:  Epilepsy Res       Date:  2017-11-28       Impact factor: 3.045

Review 10.  New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives.

Authors:  Nicolas Gaspard; Lawrence J Hirsch; Claudine Sculier; Tobias Loddenkemper; Andreas van Baalen; Judette Lancrenon; Michel Emmery; Nicola Specchio; Raquel Farias-Moeller; Nora Wong; Rima Nabbout
Journal:  Epilepsia       Date:  2018-02-24       Impact factor: 5.864

View more
  3 in total

1.  Pregabalin as adjunctive therapy in adult and pediatric patients with generalized tonic-clonic seizures: A randomized, placebo-controlled trial.

Authors:  Joseph Driscoll; Mary Almas; Gabriela Gregorian; Alla Kyrychenko; Iryna Makedonska; Jing Liu; Jeffrey Patrick; Joseph M Scavone; Jeremias Antinew
Journal:  Epilepsia Open       Date:  2021-05-16

2.  The opioid antagonist naltrexone decreases seizure-like activity in genetic and chemically induced epilepsy models.

Authors:  Morgan L Sturgeon; Rachel Langton; Shaunik Sharma; Robert A Cornell; Joseph Glykys; Alexander G Bassuk
Journal:  Epilepsia Open       Date:  2021-06-09

3.  Intestinal Flora Composition Determines Microglia Activation and Improves Epileptic Episode Progress.

Authors:  Xiaomi Ding; Jing Zhou; Li Zhao; Mingyue Chen; Shenglin Wang; Ming Zhang; Xiaodong Zhang; Guohui Jiang
Journal:  Front Cell Infect Microbiol       Date:  2022-03-09       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.